Indonesia has set an ambitious goal: eliminating malaria nationwide by 2030. At the Asia Pacific Leaders Malaria Alliance (APLMA) meeting in 2024,

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy in the world. G6PD is the first and rate-limiting enzyme in the

On 29 July 2025, EHI researchers Illene Nanine and Devin attended the seminar “Guest Lecture Future Scholar Spotlight: Precision Health Through

The Faculty of Medicine, Universitas Sumatera Utara (FK USU), in collaboration with the SingHealth Duke-NUS Global Health Institute (SDGHI), hosted

Researchers from the UBUAMA (Uncovering the Burden of Asymptomatic Malaria) project, in collaboration with Institut Teknologi Bandung (ITB) and EHI,

On 22–23 July 2025, the Surviving, Adapting, Thriving in the Next Quarter seminar was held at the National Institutes of Health, Malaysia, in